UK, South Africa to collaborate on COVID-19 vaccine development
Collaboration between the South African government, The UK and leading global organisations will see the acceleration of the development, production and access to new COVID-19 diagnostics, therapeutics and vaccines. James Duddridge, UK Minister for Africa joins CNBC Africa for more.
Wed, 30 Sep 2020 11:06:53 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- The UK government's significant financial commitment and active involvement in the COVID accelerator technology demonstrate a dedication to global vaccine access and development.
- Partnerships with global institutions and universities in both the UK and South Africa emphasize the importance of coordinated efforts in vaccine testing and production.
- The UK's support for multilateral initiatives like WHO and collaborative platforms such as Gavi underlines the country's commitment to global health and pandemic response.
The collaboration between the South African government, the United Kingdom, and leading global organizations is set to accelerate the development, production, and access to new COVID-19 diagnostics, therapeutics, and vaccines. James Duddridge, UK Minister for Africa, highlighted the importance of this project, emphasizing the commitment of the UK government to protecting everyone, including those on the African continent. With a significant financial commitment of up to 500 million pounds from Prime Minister Boris Johnson, the UK is actively involved in the COVID accelerator technology to drive progress. The Foreign Secretary's engagement with the Health Secretary in South Africa at a UN virtual meeting underscored the collaborative efforts to combat the pandemic. The UK's contribution to the COVID vaccines accelerator for 47 African countries as part of the 92 countries worldwide showcases a commitment to equitable vaccine distribution. The focus is not only on providing domestically in the UK but also supporting African nations that may struggle to procure vaccines independently. This coordinated approach involves partnerships with global institutions and universities like Oxford University, AstraZeneca, University of Lagos, and Wits in Johannesburg, ensuring comprehensive testing and development of vaccines. Minister Duddridge discussed the progress of vaccine candidates, emphasizing the importance of a multilateral solution to vaccine development. While optimistic about the advancements, he stressed the necessity of rigorous testing procedures to ensure the efficacy and safety of the vaccines. The goal is to roll out vaccines equitably to protect the most vulnerable populations, including healthcare workers and high-risk individuals such as the elderly and those with pre-existing conditions. Minister Duddridge addressed the importance of a sustainable, multilateral response to COVID-19, highlighting the economic impact on the African continent, particularly on vulnerable communities and economies heavily reliant on daily income. Amidst varying responses to the pandemic globally, the UK's continued support for the World Health Organization (WHO) through significant financial aid demonstrates a strong commitment to global health initiatives. The UK's investment in WHO, alongside engagement with organizations like Gavi, supports vital healthcare infrastructure and pandemic response efforts across Africa. Minister Duddridge emphasized the UK's stance on multilateralism and the necessity of global cooperation in addressing the challenges posed by COVID-19. As African economies grapple with the pandemic's aftermath, discussions on post-COVID economic recovery and support from international partners like the UK are crucial moving forward.